The NHS RightCare COPD pathway provides a set of resources to support local health economies to concentrate their improvement efforts where there is greatest opportunity to address variation and improve population health. It shows commissioners and providers how to ensure early detection with accurate diagnosis and how to optimise long term management to reduce hospital admissions and premature mortality.
Musculoskeletal conditions are the single biggest cause of disability in the UK, accounting for 30% of GP consultations in England. A new framework published by NHS England and others is designed to help manage MSK problems appropriately at the first point of contact, and help to relieve pressures on primary and secondary care. The framework should be of interest to commissioners, employers, regulators and practitioners.
As of April 2018, 91% of CCGs now have delegated responsibility for primary medical care. It’s doubtful whether a majority of them are fully prepared to discharge that responsibility, however. Not only will many lack the expertise and experience to take day to day decisions about the contracts they hold for general practice services, the contracting portfolios they have inherited from NHS England may be incomplete, out of date and poorly documented.
The University of Manchester and PCC have launched a toolkit to support commissioners to plan, design and evaluate services provided by community pharmacies for patients requiring medicines.
By integrating a medicines optimisation service into the patient pathway, the patient can access the expertise of a pharmacist and their team in community pharmacy, which can improve their medicines taking, reduce unplanned hospital admissions and reduce pressure on the wider health and social care system.
The content of this toolkit is based on evidence drawn from a large National Institute for Health Research (NIHR) funded study investigating organisational factors associated with variation in the quality and quantity of services provided by community pharmacies. Results of the study were reviewed by commissioning and pharmacy leaders at a subsequent workshop which informed the design of the toolkit.